Patent directory · USPTO A61K / A61P
Patents matching “Amphastar Pharmaceuticals, Inc.”
13 pharma patents match "Amphastar Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 13 pharmaceutical patents matching "Amphastar Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12383516
Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent
granted -
US 12370241
Nasal powder formulation for treatment of hypoglycemia
granted -
US 12226456
Nasal powder formulation for treatment of hypoglycemia
granted -
US 11938089
Medication delivery systems and methods
granted -
US 11524987
Highly purified recombinant human insulin (RHI) API and methods of producing the same
granted -
US 11446360
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10406210
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10322168
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10258573
Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
granted -
US 8974801
Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
granted -
US 8367734
Stable epinephrine suspension formulation with high inhalation delivery efficiency
granted -
US 7468394
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
granted -
US 6399087
Propofol formulation with enhanced microbial inhibition
expired